Imprimis Dropless

Imprimis Dropless is a multi-drug compound designed for intraocular injection following cataract surgery. It combines triamcinolone acetonide, moxifloxacin hydrochloride, and vancomycin to provide prophylactic treatment against post-operative pain, inflammation, and infection. The formulation aims to reduce or eliminate the need for patient-administered eye drops, thereby improving patient compliance and potentially decreasing overall costs associated with post-operative care. Triamcinolone acetonide acts as an anti-inflammatory corticosteroid, moxifloxacin hydrochloride is a broad-spectrum fluoroquinolone antibiotic, and vancomycin is a glycopeptide antibiotic.

Brand names

Imprimis DroplessDropless Therapy

Other names

Dropless